Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
upadacitinib (ABT-494)
Pharma
ICER blesses AbbVie's Rinvoq for RA but frets over fair pricing
ICER is still concerned about high prices of next-generation RA drugs—a stance that's not going over well among RA drugmakers and patient groups.
Arlene Weintraub
Nov 26, 2019 11:08am
Could AbbVie be a steal for investors as new meds take off?
Nov 22, 2019 10:26am
Botox aside, what can AbbVie expect from Allergan post-merger?
Nov 5, 2019 10:33am
AbbVie's Imbruvica rising in CLL despite future Calquence threat
Nov 1, 2019 10:15am
AbbVie's Rinvoq hits its marks in psoriatic arthritis trial
Oct 31, 2019 11:38am
AbbVie's Rinvoq, J&J's Spravato win backing in EU
Oct 18, 2019 11:11am
